product summary
Loading...
company name :
R&D Systems
product type :
antibody
product name :
Complement C7 Antibody [Allophycocyanin]
catalog :
NBP3-00202APC
quantity :
0.1 ml
price :
379 USD
clonality :
polyclonal
host :
domestic rabbit
conjugate :
APC
reactivity :
human
application :
ELISA
more info or order :
product information
brand :
Novus
master code :
NBP3-00202APC
SKU :
NBP3-00202APC
product name :
Complement C7 Antibody [Allophycocyanin]
sizes available :
0.1 ml
description :
The Complement C7 Antibody [Allophycocyanin] from NBP3-00202APC is a 6.7e-05 antibody to . This antibody reacts with human.
target :
Complement C7
category :
Primary Antibodies
buffer :
PBS
clonality :
Polyclonal
conjugate :
Allophycocyanin
all_available conjugate :
Alexa Fluor 594;DyLight 350;Allophycocyanin
dilution :
ELISA
host :
Rabbit
immunogen :
Produced in rabbits immunized with purified, recombinant Human Complement C7 (Accession#: P10643; Met1-Gln843)
isotype :
IgG
purity :
Antigen and protein A Affinity-purified
species :
Human
gene symbol :
C7
applications :
ELISA
USD :
379 USD
alt names :
complement component 7, complement component C7
storage :
Store at 4C in the dark.
more info or order :
company information

R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.
related products
browse more products
- Complement C7 Antibody [Janelia Fluor® 669] | NBP3-00202JF669
- FAKD3 Antibody [Alexa Fluor Plus 680] | NBP2-97546AFP680
- C1qR1/CD93 Antibody (164) [DyLight 350] | NBP2-90894UV
- C1qR1/CD93 Antibody (164) [Alexa Fluor Plus 594] | NBP2-90894AFP594
- C1qR1/CD93 Antibody (164) [Alexa Fluor Plus 647] | NBP2-90894AFP647
questions and comments
